Coronavirus News LIVE Updates: The Subject Expert Committee (SEC) of the national drug regulator on Saturday recommended that Bharat Biotech Covid-19 vaccine applicant Covaxin be approved for restricted emergency use in India, the union health ministry said. The locally-made vaccine is the second to get the expert panel's nod, after the Oxford-AstraZeneca shot was given clearance on Friday evening.
Confirming the accelerated approval, the ministry said that the SEC has granted permission to Covaxin for restricted use in emergency situations "in public interest as an abundant precaution, in clinical trial mode, specially in the context of infection by mutant strains". The committee constituted by Central Drug Standard Control Organisation had on Friday maintained that the data provided by Bharat Biotech for its coronavirus vaccine was not sufficient for grant of emergency use approval and had asked for more information, but granted its recommendation on Saturday.